Erratum to: CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis (Breast Cancer Res Treat, (2014), 143, 265-276, 10.1007/s10549-013-2811-8);CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis

Breast Cancer Research and Treatment

Volumn 143, Issue 2, 2014, Pages 265-276

  Biswas, Subir ^a   Sengupta, Suman ^a   Roy Chowdhury, Sougata ^b   Jana, Samir ^a   Mandal, Gunjan ^a   Mandal, Palash Kumar ^c   Saha, Nipun ^d   Malhotra, Vivek ^d   Gupta, Arnab ^d   Kuprash, Dmitry V ^e   Bhattacharyya, Arindam ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

^c NORTH BENGAL MEDICAL COLLEGE   (India)

^d Kothari Medical Centre   (India)

^e ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Breast cancer; CXCL13; CXCR5; Epithelial to mesenchymal transition; Lymph node metastasis; RANKL

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; GELATINASE B; NERVE CELL ADHESION MOLECULE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN; 2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; 2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; CADHERIN; CDH2 PROTEIN, HUMAN; CXCL13 PROTEIN, HUMAN; CXCR5 PROTEIN, HUMAN; FURAN DERIVATIVE; INDOLE DERIVATIVE; LEUKOCYTE ANTIGEN; MESSENGER RNA; MMP9 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SNAIL FAMILY TRANSCRIPTION FACTORS; SULFONAMIDE; TNFSF11 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADULT; AGED; ANTIGENS, CD; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL13; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FURANS; HUMANS; INDOLES; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PYRIDINES; PYRIMIDINES; RANK LIGAND; RECEPTORS, CXCR5; RNA, MESSENGER; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SULFONAMIDES; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84893684017     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-3713-3     Document Type: Erratum

References (52)

1. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540-550
2. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM (1998) Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 273:4282-4287
3. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127
4. Patel J, Channon KM, McNeill E (2013) The downstream regulation of chemokine receptor signaling: implications for atherosclerosis. Mediators Inflamm. doi: 10.1155/2013/459520
5. Latek D, Modzelewska A, Trzaskowski B, Palczewski K, Filipek S (2012) G protein-coupled receptors-recent advances. Acta Biochim Pol 59:515-529
6. Zlontik A (2004) Chemokines in neoplastic progression. Semin Cancer Biol 14:181-185
7. Longo-Imedio MI, Longo N, Trevino I, Lazaro P, Sanchez-Mateos P (2005) Clinical significance of CXCR3 and CXCR4 expression in primary melanoma. Int J Cancer 117:861-865
8. Murphy C, McGurk M, Pettigrew J et al (2005) Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res 11:4117-4127
9. Keeley EC, Mehrad B, Strieter RM (2010) CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res 106:91-111
10. Belperio JA, Keane MP, Arenberg DA et al (2000) CXC chemokines in angiogenesis. J Leukoc Biol 68:1-8
11. Vicari AP, Caux C (2002) Chemokines in cancer. Cytokine Growth Factor Rev 13:143-154
12. Murakami T, Cardones AR, Hwang ST (2004) Chemokine receptors and melanoma metastasis. J Dermatol Sci 36:71-78
13. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H, Miyasaka M (2005) Chemokines in tumor progression and metastasis. Cancer Sci 96:317-322
14. Shayan R, Achen MG, Stacker SA (2006) Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27:1729-1738
15. Li YM, Pan Y, Wei Y et al (2004) Up-regulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6:459-469
16. Bachelder RE, Wendt MA, Mercurio AM (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62:7203-7206
17. Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer. Nature 410:50-56
18. Wiseman BS, Werb Z (2002) Stromal effects on mammary gland development and breast cancer. Science 296:1046-1049
19. Kim M, Koh YJ, Kim KE et al (2010) CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res 70:10411-10421
20. Rhodes LV, Short SP, Neel NF et al (2011) Chemokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res 71:603-613
21. Dhawan P, Richmond A (2002) Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 72:9-18
22. Zhou Y, Zhang J, Liu Q et al (2005) The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells. Carcinogenesis 26:2058-2068
23. Singh S, Singh AP, Sharma B, Owen LB, Singh RK (2010) CXCL8 and its cognate receptors in melanoma progression and metastasis. Future Oncol 6:111-116
24. Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C, Huang RP (2004) Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 109:507-515
25. Meijer J, Zeelenberg IS, Sipos B, Roos E (2006) The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. Cancer Res 66:9576-9582
26. Bürkle A, Niedermeier M, Schmitt-Gräff A, Wierda WG, Keating MJ, Burger JA (2007) Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 110:3316-3325
27. Panse J, Friedrichs K, Marx A et al (2008) Chemokine CXCL13 is overexpressed in the tumor tissue and in the peripheral blood of breast cancer patients. Br J Cancer 99:930-938
28. Airoldi I, Cocco C, Morandi F, Prigione I, Pistoia V (2008) CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow. Cancer Immunol Immunother 57:541-548
29. Razmkhah M, Jaberipour M, Safaei A, Talei AR, Erfani N, Ghaderi A (2012) Chemokine and chemokine receptors: a comparative study between metastatic and non-metastatic lymph nodes in breast cancer patients. Eur Cytokine Netw 23:72-77
30. El Haibi CP, Sharma PK, Singh R, Johnson PR, Suttles J, Singh S, Lillard JW Jr (2010) PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells. Mol Cancer 9:85
31. Guarino M (2007) Epithelial-mesenchymal transition and tumor invasion. Int J Biochem Cell Biol 39:2153-2160
32. Markiewicz A, Ahrends T, Wełnicka-Jaskiewicz M et al (2012) Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer. J Transl Med 10:226
33. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142
34. Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118-132
35. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890
36. Fata JE, Kong YY, Li J et al (2000) The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103:41-50
37. Zhang L, Teng Y, Zhang Y et al (2012) C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway. Oncol Lett 3:395-400
38. Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC (2008) RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastatic genes. Prostate 68:92-104
39. Neve RM, Chin K, Fridlyand J et al (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527
40. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
41. Weigelt B, Peterse JL, van't Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591-602
42. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M (2002) Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer 100:86-91
43. http://www.breastcancerindia.net/bc/statistics/stati.htm. Accessed 15 Jun 2013
44. Singh S, Singh R, Singh UP et al (2009) Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. Int J Cancer 125:2288-2295
45. Singh S, Singh R, Sharma PK et al (2009) Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett 283:29-35
46. Del Grosso F, Coco S, Scaruffi P et al (2011) Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors. Mol Cancer Res 9:815-823
47. Ebisuno Y, Tanaka T, Kanemitsu N et al (2003) Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J Immunol 171:1642-1646
48. Peinado H, Portillo F, Cano A (2004) Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48:365-375
49. Dong C, Wu Y, Yao J et al (2012) G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest 122:1469-1486
50. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA (2003) MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113:207-219
51. El-Haibi CP, Singh R, Gupta P, Sharma PK, Greenleaf KN, Singh S, Lillard JW Jr (2012) Antibody microarray analysis of signaling networks regulated by Cxcl13 and Cxcr5 in prostate cancer. J Proteomics Bioinform 5:177-184
52. Zhao Y, Li X, Sun X, Zhang Y, Ren H (2012) EMT phenotype is induced by increased Src kinase activity via Src-mediated caspase-8 phosphorylation. Cell Physiol Biochem 29:341-352